1. Home
  2. LXEO vs LNKB Comparison

LXEO vs LNKB Comparison

Compare LXEO & LNKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • LNKB
  • Stock Information
  • Founded
  • LXEO 2017
  • LNKB 2018
  • Country
  • LXEO United States
  • LNKB United States
  • Employees
  • LXEO N/A
  • LNKB N/A
  • Industry
  • LXEO
  • LNKB
  • Sector
  • LXEO
  • LNKB
  • Exchange
  • LXEO Nasdaq
  • LNKB Nasdaq
  • Market Cap
  • LXEO 314.1M
  • LNKB 263.0M
  • IPO Year
  • LXEO 2023
  • LNKB N/A
  • Fundamental
  • Price
  • LXEO $6.29
  • LNKB $7.49
  • Analyst Decision
  • LXEO Strong Buy
  • LNKB Hold
  • Analyst Count
  • LXEO 7
  • LNKB 1
  • Target Price
  • LXEO $22.71
  • LNKB $7.50
  • AVG Volume (30 Days)
  • LXEO 623.4K
  • LNKB 43.8K
  • Earning Date
  • LXEO 11-13-2024
  • LNKB 10-28-2024
  • Dividend Yield
  • LXEO N/A
  • LNKB 4.17%
  • EPS Growth
  • LXEO N/A
  • LNKB 61.51
  • EPS
  • LXEO N/A
  • LNKB 0.17
  • Revenue
  • LXEO N/A
  • LNKB $86,138,000.00
  • Revenue This Year
  • LXEO N/A
  • LNKB N/A
  • Revenue Next Year
  • LXEO N/A
  • LNKB $9.49
  • P/E Ratio
  • LXEO N/A
  • LNKB $42.88
  • Revenue Growth
  • LXEO N/A
  • LNKB 151.51
  • 52 Week Low
  • LXEO $5.77
  • LNKB $5.86
  • 52 Week High
  • LXEO $22.33
  • LNKB $8.29
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 28.99
  • LNKB 58.47
  • Support Level
  • LXEO $5.77
  • LNKB $6.98
  • Resistance Level
  • LXEO $11.72
  • LNKB $7.59
  • Average True Range (ATR)
  • LXEO 0.85
  • LNKB 0.25
  • MACD
  • LXEO -0.19
  • LNKB -0.03
  • Stochastic Oscillator
  • LXEO 5.71
  • LNKB 55.28

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About LNKB LINKBANCORP Inc.

Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans.

Share on Social Networks: